TY - JOUR
T1 - Opioid analgesics and heroin
T2 - Examining drug misuse trends among a sample of drug treatment clients in Kentucky
AU - Victor, Grant A.
AU - Walker, Robert
AU - Cole, Jennifer
AU - Logan, T. K.
N1 - Publisher Copyright:
© 2017 Elsevier B.V.
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Background In an effort to mitigate Kentucky's prescription drug misuse, legislative intervention efforts were introduced in 2012 and 2013 to better regulate pain clinics, prescribed use of opioid analgesics, and to expand the monitoring of opioid prescriptions. The focus of this paper is primarily on opioid analgesics and heroin and the relationship of use/misuse patterns of these drugs to state drug policy initiatives. Methods A secondary data analysis of drug treatment clients (N = 52,360) was conducted to project illicit drug use trends in Kentucky. This study describes temporal and geographic trends of self-reported illicit drug use among individuals in state-funded treatment in Kentucky between fiscal year 2010 and fiscal year 2013. Results Significant reductions in the prevalence of illicit opioid use, declined from fiscal year 2010 to fiscal year 2013 (p < .01, CI = −.298 to −.215). However, heroin use rates significantly increased over the years studied, suggesting there may be a transition from prescription opioids to heroin (p < .01, CI = .143 to.178). The analysis suggests these trends may continue. Conclusions Findings suggest Kentucky's legislative efforts were effective in reducing illicit prescription opioid use, but heroin use has increased. One possible explanation for this relationship is that as prescription opioids became more difficult to obtain, users turned to heroin as a substitute. The finding of rising heroin use suggests a need for further policy initiatives to reduce heroin use, but the potential effectiveness of this policy remains unclear. Understanding trends may help to guide future policy efforts and pain management treatment strategies to where they might have their greatest impact.
AB - Background In an effort to mitigate Kentucky's prescription drug misuse, legislative intervention efforts were introduced in 2012 and 2013 to better regulate pain clinics, prescribed use of opioid analgesics, and to expand the monitoring of opioid prescriptions. The focus of this paper is primarily on opioid analgesics and heroin and the relationship of use/misuse patterns of these drugs to state drug policy initiatives. Methods A secondary data analysis of drug treatment clients (N = 52,360) was conducted to project illicit drug use trends in Kentucky. This study describes temporal and geographic trends of self-reported illicit drug use among individuals in state-funded treatment in Kentucky between fiscal year 2010 and fiscal year 2013. Results Significant reductions in the prevalence of illicit opioid use, declined from fiscal year 2010 to fiscal year 2013 (p < .01, CI = −.298 to −.215). However, heroin use rates significantly increased over the years studied, suggesting there may be a transition from prescription opioids to heroin (p < .01, CI = .143 to.178). The analysis suggests these trends may continue. Conclusions Findings suggest Kentucky's legislative efforts were effective in reducing illicit prescription opioid use, but heroin use has increased. One possible explanation for this relationship is that as prescription opioids became more difficult to obtain, users turned to heroin as a substitute. The finding of rising heroin use suggests a need for further policy initiatives to reduce heroin use, but the potential effectiveness of this policy remains unclear. Understanding trends may help to guide future policy efforts and pain management treatment strategies to where they might have their greatest impact.
KW - Drug trends
KW - Heroin
KW - Kentucky
KW - Opioids
KW - Policy
UR - http://www.scopus.com/inward/record.url?scp=85019167644&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019167644&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2017.01.008
DO - 10.1016/j.drugpo.2017.01.008
M3 - Article
C2 - 28511053
AN - SCOPUS:85019167644
SN - 0955-3959
VL - 46
SP - 1
EP - 6
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
ER -